CVR number 39842041
Industry 86.2300 Dental practice activities

Tandlægeselskabet GS ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  5.2% 5.0% 3.3% 3.1% 2.7%  
Credit score (0-100)  42 42 55 55 60  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  995 1,478 1,511 1,696 1,680  
EBITDA  333 843 856 994 995  
EBIT  193 703 716 853 855  
Pre-tax profit (PTP)  156.2 667.8 683.9 831.2 854.6  
Net earnings  94.3 432.2 480.7 753.2 622.4  
Pre-tax profit without non-rec. items  156 668 684 831 855  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  221 653 1,134 1,769 2,392  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,997 2,564 2,430 2,849 2,574  
Net Debt  -26.0 -378 -187 -648 -349  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  995 1,478 1,511 1,696 1,680  
Gross profit growth  5.3% 48.5% 2.3% 12.2% -0.9%  
Employees  0 1 1 1 1  
Employee growth %  -100.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,997 2,564 2,430 2,849 2,574  
Balance sheet change%  -7.0% 28.4% -5.2% 17.2% -9.7%  
Added value  333.0 843.4 856.3 994.0 995.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -281 -281 -281 -281 -281  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 3.0 4.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  19.4% 47.6% 47.4% 50.3% 50.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  9.3% 30.8% 28.7% 32.4% 31.6%  
ROI %  10.9% 33.1% 38.6% 54.1% 39.4%  
ROE %  54.3% 98.9% 53.8% 51.9% 29.9%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  11.1% 25.5% 46.6% 62.1% 92.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -7.8% -44.8% -21.8% -65.2% -35.1%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.2 2.2 0.2 0.6 5.1  
Current Ratio  0.2 2.2 0.2 0.6 5.1  
Cash and cash equivalent  26.0 377.6 186.5 648.1 349.0  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -123.4 209.0 -877.8 -357.2 280.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 843 856 994 995  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 843 856 994 995  
EBIT / employee  0 703 716 853 855  
Net earnings / employee  0 432 481 753 622